Search research articles
Contact Us
Filters
Showing results (191-200 of 200) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 200 results.
Thrombosis and Haemostasis
|
November 10, 2020
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim, Udaya S Tantry, Sidney C Smith, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 5, 2022
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
Michael Behnes, Shqipdona Lahu, Gjin Ndrepepa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel
Alp Aytekin, Maria Scalamogna, J J Coughlan, et al.
Thrombosis and Haemostasis
|
September 23, 2016
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial
Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen, et al.
Cardiovascular Research
|
February 16, 2019
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention
Thorsten Kessler, Bernhard Wolf, Niclas Eriksson, et al.
JACC. Cardiovascular Interventions
|
November 27, 2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update
Dominick J Angiolillo, Mattia Galli, Dimitrios Alexopoulos, et al.
European Heart Journal
|
June 10, 2021
Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy
Filippo Crea, Holger Thiele, Dirk Sibbing, et al.
The New England Journal of Medicine
|
September 3, 2019
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
Stefanie Schüpke, Franz-Josef Neumann, Maurizio Menichelli, et al.
European Heart Journal
|
January 28, 2021
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions
Christian Pristipino, Peter Germonpré, Danilo Toni, et al.
Circulation
|
June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 200) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 200 results.
Thrombosis and Haemostasis
|
November 10, 2020
The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease
Hyun Kuk Kim, Udaya S Tantry, Sidney C Smith, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 5, 2022
Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
Michael Behnes, Shqipdona Lahu, Gjin Ndrepepa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
May 13, 2024
Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel
Alp Aytekin, Maria Scalamogna, J J Coughlan, et al.
Thrombosis and Haemostasis
|
September 23, 2016
A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial
Dirk Sibbing, Dániel Aradi, Claudius Jacobshagen, et al.
Cardiovascular Research
|
February 16, 2019
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention
Thorsten Kessler, Bernhard Wolf, Niclas Eriksson, et al.
JACC. Cardiovascular Interventions
|
November 27, 2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update
Dominick J Angiolillo, Mattia Galli, Dimitrios Alexopoulos, et al.
European Heart Journal
|
June 10, 2021
Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy
Filippo Crea, Holger Thiele, Dirk Sibbing, et al.
The New England Journal of Medicine
|
September 3, 2019
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
Stefanie Schüpke, Franz-Josef Neumann, Maurizio Menichelli, et al.
European Heart Journal
|
January 28, 2021
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions
Christian Pristipino, Peter Germonpré, Danilo Toni, et al.
Circulation
|
June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium
Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Page
of 20